Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
Frontiers in Microbiology · 06.07.2023 · 14
DOI: 10.3389/fmicb.2023.1212582 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 06.07.2023. Verfasst von Geng-Hao Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Norovirus infection is a leading cause of acute gastroenteritis worldwide and can also cause harmful chronic infections in individuals with weakened immune systems. The role of the gut microbiota in the interactions between the host and noroviruses has been extensively studied. While most past studies were conducted in vitro or focused on murine noroviruses, recent research has expanded to human noroviruses using in vivo or ex vivo human intestinal enteroids culture studies. The gut microbiota has been observed to have both promoting and inhibiting effects on human noroviruses. Understanding the interaction between noroviruses and the gut microbiota or probiotics is crucial for studying the pathogenesis of norovirus infection and its potential implications, including probiotics and vaccines for infection control. Recently, several clinical trials of probiotics and norovirus vaccines have also been published. Therefore, in this review, we discuss the current understanding and recent updates on the interactions between noroviruses and gut microbiota, including the impact of norovirus on the microbiota profile, pro-viral and antiviral effects of microbiota on norovirus infection, the use of probiotics for treating norovirus infections, and human norovirus vaccine development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of General Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
- Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of Pediatrics, Division of Allergy, Asthma and Immunology, Shuang Ho Hospital, New Taipei, Taiwan.
- Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
- Broad Institute of MIT and Harvard, Cambridge, MA, United States.
Zitieren
APA
Bai, G. H., Tsai, M. C., Lin, S. C., Hsu, Y. H., & Chen, S. Y. (2023). Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1212582
Vancouver
Bai GH, Tsai MC, Lin SC, Hsu YH, Chen SY. Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1212582
BibTeX
@article{Bai2023,
author = {Bai, Geng-Hao and Tsai, Meng-Chen and Lin, Sheng-Chieh and Hsu, Yi-Hsiang and Chen, Shih-Yen},
title = {Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1212582}
}
EUVIMED